AlzeCure Pharma
1.27
SEK
+0.4 %
ALZCUR
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
1 following
+0.4%
+20.95%
-36.34%
-32.27%
-56.7%
-57.79%
-74.97%
-66.26%
-87.26%
AlzeCure Pharma is a pharmaceutical company. The company focuses on research and development of drugs used for various brain diseases, with the greatest focus on Alzheimer's disease, but also on pain. The technology and research is based on its own pharmaceutical platform, where the company develops various symptom-relieving and disease-modifying drug candidates. The head office is in Huddinge.
Read moreMarket cap
112.13M SEK
Turnover
19.76K SEK
Revenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
Financial calendar
27/2
2025
Annual report '24
5/5
2025
Interim report Q1'25
14/5
2025
General meeting '24
ShowingAll content types
AlzeCure to present at the Pharma Outsourcing conference in Stockholm
AlzeCure Pharma presenterar på Redeye Life Science Day den 3 december
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools